| ||
| MolMed presents new data for its cell based therapy TK at the ... PharmaLive.com ... a selective vascular targeting agent for the treatment of solid tumours, in Phase III for malignant pleural mesothelioma and in Phase II in colorectal, ... |
Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment